Company: TBPH
Filing Date: 2025-04-10
Form Type: DEF 14A
Source: 0001104659-25-033819
Chunk: 21

Company: Theravance Biopharma, Inc.
Filing Date: 2025-04-10
Form: DEF 14A
Chunk 21
---
. from 2008 to 2019, each of which was a biopharmaceutical company. Dr. Pakianathan also served on the board of directors of FSDC I from August 2020 to February 2021 and FSDC II from February 2021 to December 2021, each of which was a special purpose acquisition company. Dr. Pakianathan also serves on the board of directors of two privately owned biopharmaceutical companies. Dr. Pakianathan holds an M.S. and a Ph.D. from Wake Forest University, a B.Sc. from the University of Bombay, India and an M.Sc. from The Cancer Research Institute at the University of Bombay, India. We believe that Dr. Pakianathan’s qualifications to serve as our director include her experience as a biotech investor and portfolio manager, scientific experience, experience as board member of multiple biotechnology companies, broad transactional experience, knowledge of our industry and knowledge of financial and financing matters. | ​ |

There are no family relationships among any of our directors or executive officers. See “Corporate Governance” below for additional information regarding our board of directors. Resolution to be Voted Upon An ordinary resolution, being a simple majority of the votes duly cast at the Annual Meeting, is required for the election of each director. Abstentions and broker non-votes will not affect the outcome of Proposal One, other than counting towards the quorum of the meeting. The full text of the resolutions to be proposed is as follows: “RESOLVED, as an ordinary resolution, that Rick E Winningham be appointed as a director of the Company, to hold office as a Class II Director for a one-year term in accordance with the Amended and Restated Memorandum and Articles of Association of the Company.” “RESOLVED, as an ordinary resolution, that Jeremy T. Grant be appointed as a director of the Company, to hold office as a Class II Director for a one-year term in accordance with the Amended and Restated Memorandum and Articles of Association of the Company.” “RESOLVED, as an ordinary resolution, that Susannah Gray be appointed as a director of the Company, to hold office as a Class II Director for a one-year term in accordance with the Amended and Restated Memorandum and Articles of Association of the Company.” “RESOLVED, as an ordinary resolution, that Donal O’Connor be appointed as a director of the Company, to hold office as a Class II Director for a one-year